Search
Search
About
Log in
Join
Experiences with
Triple bromide
Posts
Communities
5,301 public posts
Filter results
Low-carb diet - ketogenesis - PSADT
New study from Steve Freedland et al. "
Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial
" [1] Bottom line: Low-carb diet may lenghthen
New study from Steve Freedland et al. "
Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial
" [1] Bottom line: Low-carb diet may lenghthen
pjoshea13
in
Advanced Prostate Cancer
3 years ago
Another study on T3 given to women with ongoing symptoms
This downloadable paper (I don't think I've posted this before, so apologies if I have) describes a trial of giving T3 to women patients with residual symptoms on T4 only.
Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy
This downloadable paper (I don't think I've posted this before, so apologies if I have) describes a trial of giving T3 to women patients with residual symptoms on T4 only.
Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy
diogenes
in
Thyroid UK
3 years ago
Shining a light on Protein Aggregation in Parkinson's Disease
Niacin, who knew?! Research shows that in the brain, niacin interacts with a highly-selective receptor, HCAR2, present in immune cells physically associated with amyloid plaques. When niacin activates the receptor, it stimulates beneficial actions from these immune cells. After the Alzheimer's disease
Niacin, who knew?! Research shows that in the brain, niacin interacts with a highly-selective receptor, HCAR2, present in immune cells physically associated with amyloid plaques. When niacin activates the receptor, it stimulates beneficial actions from these immune cells. After the Alzheimer's disease
SilentEchoes
in
Cure Parkinson's
3 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
To qualify for Pluvicto, one needs a positive PSMA PET scan, but...
The FDA has only approved one kind of PSMA PET indicator (Ga68PSMA11) to qualify for Pluvicto. Two kinds of PSMA PET indicators are FDA-approved for recurrent patients and high-risk patients: Pylarify and Ga68PSMA11.
Pylarify
, made by Progenics pharmaceuticals, is widely available: https://www.pylarify.com
The FDA has only approved one kind of PSMA PET indicator (Ga68PSMA11) to qualify for Pluvicto. Two kinds of PSMA PET indicators are FDA-approved for recurrent patients and high-risk patients: Pylarify and Ga68PSMA11.
Pylarify
, made by Progenics pharmaceuticals, is widely available: https://www.pylarify.com
Tall_Allen
in
Advanced Prostate Cancer
3 years ago
Clinical trial!!!
Have any of you heard of this phase one trial? The drug is Inobrodib! I believe the case number is CSS1477. If any of you could help me in regards to this I would so appreciate it. It was offered to my husband. Hopefully we can get to Boston as often as they would like. It’s three times a week for a
Have any of you heard of this phase one trial? The drug is Inobrodib! I believe the case number is CSS1477. If any of you could help me in regards to this I would so appreciate it. It was offered to my husband. Hopefully we can get to Boston as often as they would like. It’s three times a week for a
Fight11
in
Advanced Prostate Cancer
3 years ago
Lu-177 clinical trial university of Chicago
Husband is on the 5th of 6th isotopes in study. He has had very little side effects(if any). We are hearing that it is close to having FDA approval. PSA has dropped to 0.32. We are hoping to get many months without any treatment other than lupron.
Husband is on the 5th of 6th isotopes in study. He has had very little side effects(if any). We are hearing that it is close to having FDA approval. PSA has dropped to 0.32. We are hoping to get many months without any treatment other than lupron.
Cynthgob
in
Advanced Prostate Cancer
3 years ago
Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing
https://pubmed.ncbi.nlm.nih.gov/35225948/ There must be more to this but can't figure out how to expand it. Hisham F Bahmad 1, Timothy Demus 2, Maya M Moubarak 3 4, Darine Daher 5, Juan Carlos Alvarez Moreno 1, Francesca Polit 1, Olga Lopez 6, Ali Merhe 7, Wassim Abou-Kheir 3, Alan M Nieder 2 6, Robert
https://pubmed.ncbi.nlm.nih.gov/35225948/ There must be more to this but can't figure out how to expand it. Hisham F Bahmad 1, Timothy Demus 2, Maya M Moubarak 3 4, Darine Daher 5, Juan Carlos Alvarez Moreno 1, Francesca Polit 1, Olga Lopez 6, Ali Merhe 7, Wassim Abou-Kheir 3, Alan M Nieder 2 6, Robert
Scout4answers
in
Advanced Prostate Cancer
3 years ago
Ovarian Cancer clinical trial - ACTOv
Hi all, I am a patient representative with UCL and Cancer Research UK, and I am currently involved in the ACTOv trial. They recently received a funding grant for the trial and I thought it would be good to share an article published to give an overview of the trial and what it aims to do. I share this
Hi all, I am a patient representative with UCL and Cancer Research UK, and I am currently involved in the ACTOv trial. They recently received a funding grant for the trial and I thought it would be good to share an article published to give an overview of the trial and what it aims to do. I share this
Krobbo278
in
My Ovacome
3 years ago
Red Light PD Clinical Trial
https://youtu.be/HfJ6zZx2TGA
https://youtu.be/HfJ6zZx2TGA
House2
in
Cure Parkinson's
3 years ago
A webinar with the Patient Empowerment Network - Clinical Trials as an MPN Treatment Option: What You Should Know
PEN (Patient Empowerment Network) is hosting a MPN webinar entitled “Clinical Trials as an MPN Treatment Option: What You Should Know.” Watch online on Wednesday 30th March 2022, at 1 PM Eastern (10 AM PT, 12 PM CT) please note these are times for the US, please check the time for your country. In
PEN (Patient Empowerment Network) is hosting a MPN webinar entitled “Clinical Trials as an MPN Treatment Option: What You Should Know.” Watch online on Wednesday 30th March 2022, at 1 PM Eastern (10 AM PT, 12 PM CT) please note these are times for the US, please check the time for your country. In
Mazcd
MPNVoice
in
MPN Voice
3 years ago
Palmitoylethanolamide - Luteolin: Kind of Interesting
So I was bouncing around and found this article: Palmitoylethanolamide/Luteolin as Adjuvant Therapy to Improve an Unusual Case of Camptocormia in a Patient with Parkinson’s Disease: A Case Report 2021 https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8794485/ This is a single case report about a fairly
So I was bouncing around and found this article: Palmitoylethanolamide/Luteolin as Adjuvant Therapy to Improve an Unusual Case of Camptocormia in a Patient with Parkinson’s Disease: A Case Report 2021 https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8794485/ This is a single case report about a fairly
Bolt_Upright
in
Cure Parkinson's
3 years ago
OncLive 9 CLL Videos - Optimizing the Treatment of CLL With Novel Therapies and more Take-home messages from ASH 2021
The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus
The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus
lankisterguy
Volunteer
in
CLL Support
3 years ago
Neuroplasticity in Parkinson's A.
A clinical trial is recruiting https://clinicaltrials.gov/ct2/show/NCT05286736
A clinical trial is recruiting https://clinicaltrials.gov/ct2/show/NCT05286736
Farooqji
in
Cure Parkinson's
3 years ago
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Review of Pre-clinica
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Review of Pre-clinical Studies https://www.preprints.org/manuscript/202111.0050/v1 This is not peer reviewed. " Abstract Currently, there are no pharmacological treatments able to reverse
The Neuroprotective Effects of Cannabis-Derived Phytocannabinoids and Resveratrol in Parkinson’s Disease: A Systematic Review of Pre-clinical Studies https://www.preprints.org/manuscript/202111.0050/v1 This is not peer reviewed. " Abstract Currently, there are no pharmacological treatments able to reverse
Bolt_Upright
in
Cure Parkinson's
3 years ago
Does CLL CAUSE skin cancer? bone loss? pneumonia? skin issues? low Vitamin D3? Autoimmune issues like AIHA & ITP ?
The title above is click bait and I hope you will forgive me for using it. - The answers from many CLL experts would be that causation has not been proven by clinical trial data since there are ethical and statistical problems with designing the studies. - We had an interesting discussion today on
The title above is click bait and I hope you will forgive me for using it. - The answers from many CLL experts would be that causation has not been proven by clinical trial data since there are ethical and statistical problems with designing the studies. - We had an interesting discussion today on
lankisterguy
Volunteer
in
CLL Support
3 years ago
Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT)
This looks like it is the new state of the art for PCa radiation. Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer Poster on Interim Trial Data Comparing MRI-Guided vs. CT-Guided
This looks like it is the new state of the art for PCa radiation. Interim Findings from MIRAGE Phase III Randomized Trial Signal Superiority of MRIdian® MRI-guidance in Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer Poster on Interim Trial Data Comparing MRI-Guided vs. CT-Guided
Scout4answers
in
Advanced Prostate Cancer
3 years ago
Clinical Trail Updates for Patients
This is a different webinar that the one by Dr. Mesa on March 30. From our friends at MPN Advocacy & Education International Tuesday, March 29, 2022, 11:30 am- 1:00 pm EST Clinical Trial Updates for Patients If you or a loved one have myelofibrosis, polycythemia vera, or essential thrombocythemia
This is a different webinar that the one by Dr. Mesa on March 30. From our friends at MPN Advocacy & Education International Tuesday, March 29, 2022, 11:30 am- 1:00 pm EST Clinical Trial Updates for Patients If you or a loved one have myelofibrosis, polycythemia vera, or essential thrombocythemia
hunter5582
in
MPN Voice
3 years ago
LUPRON vs FIRMAGON: Is The Debate About Superiority Over? With the December FDA approval of Relugolix the debate may now be moot
PCa Commentary #149 – LUPRON vs FIRMAGON: Is The Debate About Superiority Over? Just the Facts, Please, … but with the December FDA approval of Relugolix the debate may now be moot. by Dr. Ed Weber | Feb 3, 2021 | PCa Commentary | 0 comments A great deal has been written about the comparison between
PCa Commentary #149 – LUPRON vs FIRMAGON: Is The Debate About Superiority Over? Just the Facts, Please, … but with the December FDA approval of Relugolix the debate may now be moot. by Dr. Ed Weber | Feb 3, 2021 | PCa Commentary | 0 comments A great deal has been written about the comparison between
Scout4answers
in
Advanced Prostate Cancer
3 years ago
Clinical trial using Enzalutamide and Cisplatin
My oncologist has suggested a clinical trial involving Enzalutamide and Cisplatin. Right now I am on Lynparza and my PSA has started to rise. Does anyone have any experience or information on this trial?
My oncologist has suggested a clinical trial involving Enzalutamide and Cisplatin. Right now I am on Lynparza and my PSA has started to rise. Does anyone have any experience or information on this trial?
Newyork6264
in
Advanced Prostate Cancer
3 years ago
Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from ANAVEX®2-73-PDD-001 Parkinson’s Disease Dementia Study
https://finance.yahoo.com/news/anavex-life-sciences-announces-presentation-110000370.html All MDS-UPDRS Part I, II, III, IV sub-scores improved, including substantial majority of individual items between 71% and 92% SIGMAR1 mRNA expression significantly increased in ANAVEX®2-73-treated patients vs placebo
https://finance.yahoo.com/news/anavex-life-sciences-announces-presentation-110000370.html All MDS-UPDRS Part I, II, III, IV sub-scores improved, including substantial majority of individual items between 71% and 92% SIGMAR1 mRNA expression significantly increased in ANAVEX®2-73-treated patients vs placebo
John_morris71
in
Cure Parkinson's
3 years ago
1
...
64
65
66
...
100
Next page
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
1326 results
Cure Parkinson's
664 results
CLL Support
633 results
View top 10 communities
Sort by
Most Relevant
Newest